Filter
169
Filtered Results: 169
Text search:
trypanosoma
cruzi
Featured
Recommendations
6
New Publications
18
Language
Document type
Studies & Reports
55
Guidelines
30
No document type
24
Fact sheets
20
Resource Platforms
19
Strategic & Response Plan
6
Manuals
5
Videos
4
Dashboards/Maps
2
Infographics
2
Training Material
1
Situation Updates
1
Countries / Regions
Global
34
Latin America and the Carribbean
27
Colombia
9
Africa
7
Venezuela
5
Argentina
5
Bolivia
4
Mexico
3
West and Central Africa
3
Paraguay
3
North America
3
East and Southern Africa
3
Kenya
2
Chile
2
Peru
2
USA
2
Brazil
2
El Salvador
1
China
1
Cameroon
1
Guinea
1
Germany
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Western Pacific Region
1
Western and Central Europe
1
Uruguay
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Uganda
1
Honduras
1
Angola
1
Chad
1
South Sudan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Chagas
35
Studies & Reports
19
Disease Prevention & Control
19
Guidelines
12
Vector Control
9
Communicable Diseases
3
Hematology
3
General Guidelines
3
Policies
3
Drugs & Medical Equipment
3
Quality Control & Assurance
3
COVID-19
2
Health System Strengthening
2
Policies & Guidelines HIV & TB
2
Women & Child Health
2
NTDs & Others
2
Leishmaniasis
2
Pediatrics
1
Countries
1
Medical Devices & Equipment
1
Statistics
1
General Guidelines
1
Communicable Diseases
1
Parasitology
1
Human African Trypanosomiasis
1
Laboratory Quality Assurance
1
HIV & STI
1
Pharmacy & Technologies
1
Toolboxes
Studies & Reports
28
Information & Education Material (IEC)
24
Chagas
20
Clinical Aspects & Diagnostics
17
Overview, Studies & Reports
13
Statistics & Facts
11
Studies & Reports
8
Vector control
7
Capacity Building & Resources
6
Zoonoses
4
NTDs
4
Clinical Aspects & Diagnostics
4
Latin America & the Carribean
3
Reports & Studies
3
Country specific documents
2
Pharmacy
2
Essential Medicines & Devices Lists
2
Strategies & Roadmaps
2
NTDs General
2
Prevention & Control
2
Key Resources
1
Sustainable Development Goals
1
Global Impact: Socio-economic, health services, TB & HIV
1
Quality Assurance
1
Public Health
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Information & Education Material (IEC)
1
Videos
1
Policies & Strategies
1
General
1
Co-Morbidities (except TB)
1
Human Rights & the Right to Health
1
Others
1
Болезнь Шагаса, известная также как американский трипаносомоз, — потенциально опасное для жизни заболевание, вызываемое простейшим паразитом Trypanosoma cruzi.
Principaux faits
D’après les estimations, 6 à 7 millions de personnes dans le monde sont infectées par Trypanosoma cruzi (T. Cruzi), le parasite responsable de la maladie de Chagas. La plupart de ces personnes vivent en Amérique latine.
La transmission à l’être humain se fait principalem...
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Chagas disease is increasingly reported in Latin American migrants who have settled in Europe. It has rarely been reported in the UK due to lack of testing and awareness.
Chagas disease (American trypanosomia...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Front. Public Health, 02 July 2019 Sec. Infectious Diseases: Epidemiology and Prevention
Volume 7 - 2019 | https://doi.org/10.3389/fpubh.2019.00166
Chagas disease (CD) is an anthropozoonosis caused by the protozoan parasite Trypanosoma cruzi, that affects about 6–8 million people worldwide (1) a...
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is known as the silent disease. An estimated 8 million people have the disease and most of them do not know that they are infected.
WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical exposure to infection is crucial for assessing progress and for und...
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is known as the silent disease. An estimated 8 million people have the disease and most of them do not know that they are infected.
Due to the particular Amazonian situation of vectorial transmission based mostly on the wild cycle of Trypanosoma cruzi with diversity of triatomine vectors involved in effective transmission, and the variety of eco-epidemiological situations that facilitate such transmission, the countries of the A...
La enfermedad de Chagas (ECha), resultado de la infección por el Trypanosoma cruzi, afecta varias poblaciones de las
zonas rurales de Suramérica y América Central. En los últimos años la enfermedad ha cobrado importancia epidemiológica no sólo porque se ha incrementado la detección de caso...
Chronic manifestations of Chagas disease present as disabling and life-threatening conditions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mechanisms underlying Trypanosoma cruzi’s infection and the host-parasit...
A century after its discovery, Chagas' disease still represents a major public health challenge in Latin America. Moreover, because of growing population movements, an increasing number of cases of imported Chagas' disease have now been detected in non-endemic areas, such as North America and some E...
In areas of Mexico, Central America, and South America, where the Trypanosoma cruzi parasite is present in triatomine bugs, improved housing and spraying insecticide inside housing to eliminate the bugs has significantly decreased the spread of Chagas disease. Screening of blood donations for Chagas...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
Revista Médica del Hospital General de México, Vol. 81. Issue 3.Pages 154-164 (July - September 2018)
Chagas disease is a parasitic zoonosis caused by Trypanosoma cruzi, a protozoan whose transmission to humans is primarily vector-borne. It is estimated that 6–8 million people worldwide are inf...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
Carlos Chagas discovered American trypanosomiasis, also named Chagas disease (CD) in his honor, just over a century ago. He described the clinical aspects of the disease, characterized by its etiological agent (Trypanosoma cruzi) and identified its insect vector. Initially, CD occurred only in Latin...
La enfermedad de Chagas, también conocida como tripanosomiasis americana, es causada por el parásito Trypanosoma cruzi. La forma más común de contraer la infección es a través del contacto con las heces de un insecto triatominio (conocido con los nombres de chinche besucona, benchuca, vinchuca...
A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations s...
